Gutting edge: Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection

Journal of Immunology

Volumn 160, Issue 7, 1998, Pages 3081-3085

  Celluzzi, Christina M ^a   Falo Jr , Louis D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL INTERACTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL; ADOPTIVE IMMUNOTHERAPY; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CELL COMMUNICATION; CELL CULTURE; CELL FUSION; COCULTURE; CYTOTOXICITY TEST; GRAFT REJECTION; IMMUNOLOGY; LUNG TUMOR; MELANOMA; METHODOLOGY; TRANSPLANTATION;

CANCER VACCINE;

ANIMALS; CANCER VACCINES; CELL COMMUNICATION; CELL FUSION; COCULTURE TECHNIQUES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GRAFT REJECTION; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032036433     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cohen, P. A., P. Hwu, and S. A. Rosenberg. 1996. Adoptive cellular immunotherapy and gene therapy. In Cancer Chemotherapy and Biotherapy, 2nd Ed. B. A. Chabner and D. L. Longo, eds. Lippincott-Raven Publishers, Philadelphia, pp. 721-747.
2. Townsend, A., and A. Trowsdale. 1993. The transporters associated with antigen presentation. Semin. Cell Biol. 4:53.
3. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to MHC class I molecule restricted T lymphocytes. Adv. Immunol. 52:1.
4. Steinman, R. M., M. Witmer-Pack, and K. Inaba. 1993. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329:1.
5. Henderson, R. A., and O. J. Finn. 1996. Human tumor antigens are ready to fly. Adv. Immunol. 62:217.
6. Falo, L. D., Jr., M. Kovacovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1:649.
7. Suto R., and P. K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585.
8. Steinman, R. M. 1996. Dendritic cells and immune-based therapies. Exp. Hematol. 24:859.
9. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
10. Porgador, A., D. Snyder, and E. Gilboa. 1996. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:2918.
11. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, L., C. Celluzzi, L. D. Falo, C. J. Melief, S. T. Ildstad, W. M. Kast, A. B. DeLeo and M. T. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1:1297.
12. Ossevoort, M. A., M. C. Feltkamp, K. J. van Veen, C. J. Melief, and W. M. Kast. 1995. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor. J. Immunother. 18:86.
13. Conry, R. M., A. F. LoBuglio, F. Loechel, S. E. Moore, L. A. Sumerel, D. L. Barlow, and D. T. Curiel. 1995. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther. 2:59.
14. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo, Jr. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122.
15. Irvine, K. R., J. B. Rao, S. A. Rosenberg, and N. P. Restifo. 1996. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156:238.
16. Falo, L. D., and M. T. Lotze. 1997. Cancer vaccines. In Manual of Clinical Immunology. C. de Macario, ed. ASM Press, Washington, DC, 1041.
17. Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I restricted tumor antigens. Science 264:961.
18. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
19. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
20. Guo, Y., M. Wu, H. Chen, X. Wang, G. Liu, G. Li, J. Ma, and M. Sy. 1994. Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 263:518.
21. Gong, J., Chen, D., Kashiwaba, M., and D. Kufe. 1997. Induction of antitumor activity by immunization with fusions of dendritic cells and carcinoma cells. Nat. Med 3:558.
22. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach. 1994. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67.
23. Rock, K. L., L. Rothstein, and S. Gamble. 1990. Generation of class I MHC restricted T-T hybridomas. J. Immunol. 145:804.
24. Inaba, K., and R. M. Steinman. 1986. Accessory cell T lymphocyte interactions: antigen-dependent and antigen-independent clustering. J. Exp. Med. 163:247.
25. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
26. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
27. Bellone M., G. Iezzi, P. Rovere, G. Galati, A. Ronchetti, M. P. Protti, J. Davoust, C. Rugarli, and A. A. Manfredi. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391.
28. Gabrilovich, D., F. Ciernik, and D. P. Carbone. 1996. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell. Immunol. 170:101.
29. Gabrilovich, D. I., H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny, S. Nadaf, D. Kavanaugh, and D. P. Carbone. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2:1096.
30. Gabrilovich, D. I., S. Nadaf, J. Corak, J. A. Berzofsky, and D. P. Carbone. 1996. Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell. Immunol. 170:111.